Comerica Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
49,660
+42,308
| +575% | +$1.54M | 0.01% | 1195 |
|
|
2025
Q1 | $266K | Buy |
7,352
+6,049
| +464% | +$219K | ﹤0.01% | 2166 |
|
|
2024
Q4 | $54.8K | Sell |
1,303
-221
| -15% | -$9.3K | ﹤0.01% | 2779 |
|
|
2024
Q3 | $84.7K | Buy |
1,524
+396
| +35% | +$22K | ﹤0.01% | 2641 |
|
|
2024
Q2 | $46.4K | Sell |
1,128
-261
| -19% | -$10.7K | ﹤0.01% | 2773 |
|
|
2024
Q1 | $64.9K | Buy |
1,389
+58
| +4% | +$2.71K | ﹤0.01% | 2678 |
|
|
2023
Q4 | $63.7K | Buy |
1,331
+264
| +25% | +$12.6K | ﹤0.01% | 2650 |
|
|
2023
Q3 | $38K | Sell |
1,067
-1,488
| -58% | -$53K | ﹤0.01% | 2786 |
|
|
2023
Q2 | $16 | Buy |
+2,555
| New | +$16 | ﹤0.01% | 308 |
|
|
2021
Q2 | – | Sell |
-1,998
| Closed | -$219K | – | 2358 |
|
|
2021
Q1 | $219K | Sell |
1,998
-188
| -9% | -$20.6K | ﹤0.01% | 2232 |
|
|
2020
Q4 | $307K | Buy |
2,186
+3
| +0.1% | +$421 | ﹤0.01% | 2122 |
|
|
2020
Q3 | $203K | Buy |
+2,183
| New | +$203K | ﹤0.01% | 2188 |
|